Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
PaperCitations, authors & open-access status
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 316 citations, 2020 year and hybrid oa status.
316
Citations
2020
Year
hybrid
OA Status